Get the Stockscreener App
3.38
1.81%
0.06
Pre-market:
3.28
-0.10
-2.96%
Dna X Inc stock is traded at $3.38, with a volume of 8,256.
It is up +1.81% in the last 24 hours and down -0.29% over the past month.
DNA X Inc is engaged in providing crypto trading services through its online platform, enabling users to buy, sell, and exchange cryptocurrencies, as well as execute automated trading strategies between currency pairs. The company generates revenue from commissions and fees on trading activity.
See More
Previous Close:
$3.32
Open:
$3.49
24h Volume:
8,256
Relative Volume:
0.32
Market Cap:
$5.03M
Revenue:
$27.40M
Net Income/Loss:
$-17.12M
P/E Ratio:
-0.0316
EPS:
-106.8896
Net Cash Flow:
$-24.99M
1W Performance:
-2.59%
1M Performance:
-0.29%
6M Performance:
-32.67%
1Y Performance:
-65.20%
1-Day Range:
$3.3783
$3.7499
1-Week Range:
$3.32
$3.80
52-Week Range:
$2.5211
$16.97
Dna X Inc Stock (SONM) Company Profile
Name
Dna X Inc
Sector
Industry
Phone
650-378-8100
Address
4445 EASTGATE MALL, SAN DIEGO, TX
Compare SONM vs MSFT, PLTR, ORCL, CRWD, FTNT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SONM
Dna X Inc
|
3.38 | 4.94M | 27.40M | -17.12M | -24.99M | -106.89 |
MSFT
Microsoft Corp
|
484.31 | 3.58T | 318.27B | 125.22B | 72.92B | 16.79 |
PLTR
Palantir Technologies Inc
|
175.19 | 412.22B | 5.22B | 2.29B | 2.69B | 0.8876 |
ORCL
Oracle Corp
|
143.81 | 411.30B | 67.36B | 17.31B | -23.69B | 5.8248 |
CRWD
Crowdstrike Holdings Inc
|
201.63 | 216.81B | 5.09B | -24.89M | 1.43B | -0.0471 |
FTNT
Fortinet Inc
|
152.85 | 115.93B | 7.11B | 1.95B | 2.44B | 2.5883 |
Dna X Inc Stock (SONM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-18-19 | Initiated | B. Riley FBR | Buy |
| Jul-09-19 | Upgrade | National Securities | Neutral → Buy |
| Jun-10-19 | Initiated | National Securities | Neutral |
| Jun-04-19 | Initiated | Lake Street | Buy |
| Jun-04-19 | Initiated | Oppenheimer | Outperform |
View All
Dna X Inc Stock (SONM) Latest News
DNA X Q2 EPS improves to $(0.91) from $(14.15) YoY - scanx.trade
DNA X, Inc. 2Q 2026: Revenue $0 EPS $(0.92) — 10-Q Summary - TradingView
SONM: Net income surged to $5.1M as the company pivoted to crypto trading and raised $5M in new capital - TradingView
DNA X (Nasdaq: SONM) profits from phone sale while crypto platform is in the red - Stock Titan
DNA X: Q2 Earnings Snapshot - marketscreener.com
C&F Financial Corporation Announces Quarterly Dividend - The Manila Times
Beam Global Reports Second Quarter 2026 Operating Results - The Manila Times
DNA X raised $5 million after its quarter ended, while its trading platform had no revenue - Stock Titan
DNA (SONM) Quarter in Focus: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Market Reaction: The Stock Ends Down 0.60% in Latest TradingGuidance Update - Vinanet
12 Information Technology Stocks Moving In Monday's After-Market Session - Benzinga
Aon plc (AON) Holds Near $355.83 as Insurance Broker Consolidates Between Support and ResistanceHigh Volume Node - Vinanet
Sonim Technologies delays quarterly filing amid consolidation - TipRanks
DNA X, Inc. (SONM) delays Q2 2026 filing but projects smaller net loss - Stock Titan
SONM Q2'26 Earnings: EPS estimate is 5.22 USD - TradingView
Creative Realities, Inc. (CREX) Stock Price, News, Quote & History - finance.yahoo.com
DNA X, Inc. (SONM) raises $2.5M and targets Nasdaq equity rule compliance - Stock Titan
DNA X, Inc. (SONM) investor Lytton discloses 6.8% stake in latest 13G/A - Stock Titan
DNA X Inc. (SONM) Holds Flat at $3.56 as Range-Bound Trading PersistsChannel Breakout - Vinanet
Integrated DNA Technologies Scientists Set New Performance Benchmark for CRISPR Off-Target Nomination - Yahoo Finance
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Slammed 36% But Getting In Cheap Might Be Difficult Regardless - 富途牛牛
DNA X, Inc. announced that it has received $5.000004 million in funding from DNA Holdings Venture, Inc. - marketscreener.com
How DNA's Double Helix Structure Was Discovered - Encyclopedia Britannica
DNA X Inc. (SONM) Slips 1.69% as Shares Test Key Support at $3.60Channel Projection - dars.gov.et
Token Talk Inc. (DNAX) stock price, news, quote and history - Yahoo Finance UK
Ginkgo Bioworks (NYSE: DNA) plans Q2 2026 results presentation and Q&A - Stock Titan
DNA X, Inc. Revenue Breakdown – NASDAQ:SONM - TradingView
VEON Ltd. (VEON) stock price, news, quote and history - Yahoo Finance UK
VEON Ltd. (VEON) Stock Price, News, Quote & History - Yahoo! Finance Canada
YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services - The Manila Times
Restriction-enzyme DNA fingerprinting method explained - Encyclopedia Britannica
12 Information Technology Stocks Moving In Monday's Pre-Market Session - Benzinga
DNA Sequencing Market Size to Hit USD 57.39 Billion by 2035 - Precedence Research
SAY Q2 2026 Earnings: Significant EPS Miss Raises ConcernsEstimate Uncertainty - dars.gov.et
Sonim Technologies Strengthens Capital Structure With Preferred Financing - The Globe and Mail
12 Information Technology Stocks Moving In Thursday's After-Market Session - Benzinga
DNA X, Inc. Enters Securities Purchase Agreement and Designates Series B Preferred Stock in Major 2026 Transaction - Minichart
DNA X Raises $8.1 Million Via Series B Preferred; $5.0 Million Cash, $3.1 Million Note Cancelled - TradingView
YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations - The Manila Times
SONM Q3 2024 Earnings: Narrower-Than-Expected Loss, Stock Gains 2.14%Consensus Miss Rate - dars.gov.et
Cisco Catalyst 9300 Series Switches from Cisco Systems Inc.subscription-first campus networking p - AD HOC NEWS
Nextera Library Preparation Kit from Takara Holdings Incstreamlined NGS workflows for busy labs - AD HOC NEWS
DNA X, Inc. announced that it expects to receive $4.999998 million in funding from DNA Holdings Venture, Inc. - marketscreener.com
Applied DNA Sciences Named B2i Digital Featured Company to Share BNB-Focused Treasury Shift with Investors - The National Law Review
Study: Gen-Z and Millennials Are Aging Faster Than Their Parents—With Alarming Health Consequences - inc.com
Price to book forward of DNA X, Inc. – NASDAQ:SONM - TradingView
Price to earnings forward of DNA X, Inc. – NASDAQ:SONM - TradingView
Price to sales forward of DNA X, Inc. – NASDAQ:SONM - TradingView
12 Information Technology Stocks Moving In Friday's Intraday Session - Benzinga
WhatsApp CEO Kunal Shah said Indians don’t value time. Sanskrit scholar responds - ThePrint
Enterprise value to revenue forward of DNA X, Inc. – MUN:J6P - TradingView
Alex Murdaugh defense points to unknown male DNA in push for new testing - 930 WFMD Free Talk
Dna X Inc Stock (SONM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.89%
2.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):